Related Experiment Video
Updated: Jun 26, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Psoriasis and Risk of Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea.
Kyeong Min Han1,2, Dae Myoung Yoo1,2, Ho Suk Kang2,3
1Hallym Data Science Laboratory, Hallym University College of Medicine, Anyang 14068, Republic of Korea.
Diseases (Basel, Switzerland)
|June 25, 2026
Summary
Psoriasis does not increase colorectal cancer (CRC) risk. A large Korean study found no significant association between psoriasis and CRC, suggesting no need for extra screening for CRC in psoriasis patients.
Area of Science:
- Dermatology
- Gastroenterology
- Oncology
- Epidemiology
Background:
- Psoriasis is a chronic inflammatory disease linked to higher cancer risk.
- The association between psoriasis and colorectal cancer (CRC) is not well-established, especially in Asia.
- Rising CRC incidence in Asia necessitates understanding its risk factors.
Purpose of the Study:
- To investigate the association between psoriasis and the risk of developing colorectal cancer (CRC).
- To determine if psoriasis independently contributes to CRC risk in a large population cohort.
Main Methods:
- Nationwide longitudinal cohort study (2002-2019) using Korean National Health Insurance data.
- 16,670 psoriasis patients matched 1:4 with 66,680 controls.
- Propensity score weighting and Cox proportional hazards models were used to analyze CRC incidence.
Main Results:
- Psoriasis was not associated with an increased risk of colorectal cancer (adjusted HR = 0.96; 95% CI: 0.83-1.10).
- Kaplan-Meier analysis showed no significant difference in cumulative CRC incidence between groups.
- Subgroup analyses confirmed consistent null findings across various demographic and comorbidity strata.
Conclusions:
- Psoriasis is not independently associated with an increased risk of colorectal cancer in the Korean population.
- The findings do not support additional CRC surveillance for psoriasis patients beyond standard guidelines.
- Psoriasis does not appear to contribute to CRC risk at a population level.
Related Concept Videos
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

